Cargando…

Heterogeneity of p53 Mutational Status in Esophageal Squamous Cell Carcinoma

In esophageal squamous cell carcinoma, p53 gene mutations have been analyzed for inter‐ or intra‐patient heterogeneity but only a few studies have investigated intratumoral heterogeneity. We investigated this question within individual esophageal cancers, and also in their lymph‐node metastases in 8...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuwabara, Shirou, Ajioka, Yoichi, Watanabe, Hidenobu, Hitomi, Jiro, Nishikura, Ken, Hatakeyama, Katsuyoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1998
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921814/ https://www.ncbi.nlm.nih.gov/pubmed/9617346 http://dx.doi.org/10.1111/j.1349-7006.1998.tb00578.x

Ejemplares similares

Heterogeneity of p53 Mutational Status in Intramucosal Carcinoma of the Colorectum
por: Yamada, Satoshi, et al.
Publicado: (2001)

Mutations of p53 in Morphologically Non‐neoplastic Mucosa of Long‐standing Ulcerative Colitis
por: Takaku, Hideya, et al.
Publicado: (2001)

Alteration of p53 Clonality Accompanying Colorectal Cancer Progression
por: Kuwabara, Akifumi, et al.
Publicado: (1998)

Multiple K‐ras Mutations in Hyperplasia and Carcinoma in Cases of Human Pancreatic Carcinoma
por: Matsubayashi, Hiroyuki, et al.
Publicado: (1999)

Alpha-methylacyl-coenzyme A racemase expression in neuroendocrine neoplasms of the stomach
por: Annenkov, Alexey, et al.
Publicado: (2012)

Not Infrequent K‐ras Mutations in Depressed‐type Early Colorectal Carcinomas Larger than 10 mm
por: Kazama, Shinsuke, et al.
Publicado: (2002)

Assessment of lymph node status in gallbladder cancer: location, number, or ratio of positive nodes
por: Shirai, Yoshio, et al.
Publicado: (2012)

Assessment of Gastric Phenotypes Using Magnifying Narrow-Band Imaging for Differentiation of Gastric Carcinomas from Adenomas
por: Kobayashi, Masaaki, et al.
Publicado: (2014)

Alteration of p53-binding protein 1 expression as a risk factor for local recurrence in patients undergoing resection for extrahepatic cholangiocarcinoma
por: Wakai, Toshifumi, et al.
Publicado: (2021)

The High Expression of p53 Is Predictive of Poor Survival Rather TP53 Mutation in Esophageal Squamous Cell Carcinoma
por: Jin, Yan, et al.
Publicado: (2023)

Therapeutic implications of intratumor heterogeneity for TP53 mutational status in Burkitt lymphoma
por: Derenzini, Enrico, et al.
Publicado: (2015)

Extremely High Tp53 Mutation Load in Esophageal Squamous Cell Carcinoma in Golestan Province, Iran
por: Abedi-Ardekani, Behnoush, et al.
Publicado: (2011)

PRIMA‐1 induces p53‐mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation
por: Furukawa, Haruna, et al.
Publicado: (2017)

Mutations, Differential Gene Expression, and Chimeric Transcripts in Esophageal Squamous Cell Carcinoma Show High Heterogeneity()
por: Souza-Santos, Paulo Thiago de, et al.
Publicado: (2018)

Biological Significance of Tumor Heterogeneity in Esophageal Squamous Cell Carcinoma
por: Lin, Lehang, et al.
Publicado: (2019)

MET overexpression and intratumor heterogeneity in esophageal squamous cell carcinoma
por: Abboud, H.S., et al.
Publicado: (2021)

Heterogeneous Nuclear Ribonucleoprotein B1 Expressed in Esophageal Squamous Cell Carcinomas as a New Biomarker for Diagnosis
por: Matsuyama, Satoru, et al.
Publicado: (2000)

Mutations in Zinc‐binding Domains of p53 as a Prognostic Marker of Esophageal‐cancer Patients
por: Kihara, Chikashi, et al.
Publicado: (2000)

DEC2 expression antagonizes cisplatin-induced apoptosis in human esophageal squamous cell carcinoma
por: Sato, Hidenobu, et al.
Publicado: (2017)

The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma
por: Omura, Go, et al.
Publicado: (2017)

Non-disruptive mutation in TP53 DNA-binding domain is a beneficial factor of esophageal squamous cell carcinoma
por: Huang, Minran, et al.
Publicado: (2020)

Prospective Observational Study of Imatinib Therapy in Japanese Patients with Advanced Gastrointestinal Stromal Tumors: Long-term Follow-up and Second Malignancy
por: Kanda, Tatsuo, et al.
Publicado: (2012)

Clonal Heterogeneity in Human Esophageal Squamous Cell Carcinomas on DNA Analysis
por: Hori, Hikaru, et al.
Publicado: (1996)

Genetic Heterogeneity of Esophageal Squamous Cell Carcinoma with Inherited Family History
por: He, Wenwu, et al.
Publicado: (2020)

Tumor Protein p53 and K -ras Gene Mutations in Peruvian Patients with Gallbladder Cancer
por: Vidaurre, Tatiana, et al.
Publicado: (2019)

Overexpression of WRAP53 Is Associated with Development and Progression of Esophageal Squamous Cell Carcinoma
por: Rao, Xuguang, et al.
Publicado: (2014)

p53 molecular approach to diagnosis and treatment of esophageal squamous cell carcinoma
por: Shimada, Hideaki
Publicado: (2018)

Δ133p53/FLp53 Predicts Poor Clinical Outcome in Esophageal Squamous Cell Carcinoma
por: Tu, Qimin, et al.
Publicado: (2020)

p53 Gene Deficiency Does Not Enhance Instability of Mouse Minisatellites in Somatic Cells of Normal Tissues
por: Ohashi, Manabu, et al.
Publicado: (1996)

Integration of Tumor Heterogeneity for Recurrence Prediction in Patients with Esophageal Squamous Cell Cancer
por: Mai, Zihang, et al.
Publicado: (2021)

Influences of intratumoral heterogeneity on assessment of tumor microenvironment in esophageal squamous cell carcinoma
por: Sugawara, Kotaro, et al.
Publicado: (2022)

Expression status of p53 and organic cation transporter 1 is correlated with poor response to preoperative chemotherapy in esophageal squamous cell carcinoma
por: Izutsu, Masahiro, et al.
Publicado: (2022)

Allelic Losses in Mouse Skin Tumors Induced by γ‐Irradiation of p53 Heterozygotes
por: Miyazawa, Tomonori, et al.
Publicado: (2002)

Particular gene upregulation and p53 heterogeneous expression in TP53-mutated maxillary carcinoma
por: Kudo, Itsuhiro, et al.
Publicado: (2017)

Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
por: Monti, Paola, et al.
Publicado: (2020)

The high expression instead of mutation of p53 is predictive of overall survival in patients with esophageal squamous‐cell carcinoma: a meta‐analysis
por: Zhao, Ziran, et al.
Publicado: (2016)

Yield of p53 expression in esophageal squamous cell cancer and its relationship with survival
por: Sankalecha, Tushar H., et al.
Publicado: (2017)

Comprehensive immunohistochemical analysis of tumor microenvironment immune status in esophageal squamous cell carcinoma
por: Hatogai, Ken, et al.
Publicado: (2016)

Multiple Esophageal Squamous Papillomas
por: Makise, Satoshi, et al.
Publicado: (2019)

Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients
por: Alsner, J, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_66m8sapkfgiiq3ocm0kmcs1q7o